missed sales targets by Apple to solve a sell-off on wall street. The key US indices Dow Jones, Nasdaq and S&P 500 fell shortly after the opening on Thursday of up to 2.9 percent.
Because of a weakening China sales of its iPhones, Apple was reported to be several billion dollars behind his self-imposed sales target for the past quarter – for the first time in about twelve years. “This shows how to get out of a slower growth and a trade war is a deadly Cocktail for the investor sentiment mixes,” said Naeem Aslam, chief market analyst of the broker house think markets.
at the Beginning of September, Apple shares traded at us $ 228, at 3. January, you crashed on 143. (Chart: financial and economic)
shares of Apple fell by 9.1 per cent, and taxes on the biggest daily loss in six years. The Apple Outlook for the fed stockbrokers, in addition to speculation of a further cooling of the Chinese economy. Therefore, investors bailed out of companies whose business is heavily dependent on the world’s second-largest economy. The title of the Airbus-rival Boeing, and the construction machinery manufacturer Caterpillar lost more than a percent.
Weak sales Delta Air Lines is sending to descent
quarter-over-quarter revenue below market expectations, also Delta Air Lines brockt the largest price fall since three and a half years. The share of the US airline fell on Thursday by ten percent to a One-year Low of 44,59 dollars. In its Wake, the title of the competitors United and Southwest, up to 6.8 percent lost. The papers of American Airlines, plummeted temporarily by as much as eleven percent and were 28,81 Dollar as cheap as the last two and half years ago. In Europe, Lufthansa, Air France and British Airways-parent IAG up to 2.9 per cent lost.
Delta is generated to preliminary calculations, in the past quarter, sales of 10,73 billion dollars. Analysts had expected average of 10.85 billion dollars.
pharmaceuticals-Acquisition for 74 billion
The papers of Celgene scho 32 percent shooting in the height – as strong as never before. The pharmaceutical company Bristol-Myers Squibb wants to take over the biotech company for 74 billion dollars. Bristol-title collapsed by almost eight percent and were 46,45 Dollar as cheap as the last five years ago. (anf/Reuters)
Created: 03.01.2019, 16:20 PM
